1. All Products
  2. DVACVTYP - Vaccine Typhoid
  3. VACCINE TYPHOID, polysac. "Typhim Vi", 1 dose, multid. vial
Public Pricelist

VACCINE TYPHOID, polysac. "Typhim Vi", 1 dose, multid. vial

https://medicalguidelines.msf.org/en/node/274
https://unicat.msf.org/cat/product/12424
NST DVACVTYP2VD

Valid Article

Former Code(s): -X
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
19.3 - Vaccines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J07AP03
Anatomical Therapeutic Chemical Classification according to WHOCC
P
The order of this product needs to be justified and is only acceptable under certain conditions.
0208
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

VACCINE TYPHOID polysaccharide unconjugate

CAUTION

The multidose vaccine is worded and codified by unit (= 1 dose) to make the order easier.

Please always consider the MSF STD (Typhoid Conjugate Vaccine-TCV) before ordering a NST.

Therapeutic Action

Purified Vi capsular polysaccharide of Salmonella typhi (Ty2 strain)

Unconjugate vaccine

Indications

Active immunisation against typhoid fever caused by Salmonella enterica serovar typhi, S. typhi in adults and children over 2 years of age.

This typhoid unconjugate polysaccharide vaccine should be replaced by the typhoid conjugate vaccine.

The typhoid conjugate vaccine (TCV) offers a broader age range (can be administered from the age of 6 months) and longer-lasting protection (probably several years) than the thyphoid unconjugate polysaccharide vaccine administered from the age of 2 years, with protection for 2 years.

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Solution for injection

Must be given by IM route.

The syringe presentation is intended for international staff only.

Orders are always done in number of doses and not in number of vials! (See Preliminary remarks on Vaccines)

Precautions for Use

Do not administer to children under 2 years of age.

As with all injectable vaccines and/or immunoglobulins, appropriate medical treatment should always be readily available in case of rare anaphylactic reactions following the administration of the product.

Storage

  • Keep refrigerated between 2ºC and 8ºC - Protect from sunlight
  • Do not freeze.
  • Opened vials: store between 2°C and 8°C for up to 6 hrs.
  • The vaccine vial monitor (VVM) is mandatory on each vaccine.

(Cf Introduction: Thermosensitive products)